Ceci est une version HTML d'une pièce jointe de la demande d'accès à l'information 'Any document related to hemp-derived cannabidiol (CBD) in light of Case C-663/18'.



Ref. Ares(2022)4749020 - 29/06/2022
From:
To:
)
Cc:
Subject:
CBD - Interpretation for cosmetics
Date:
lundi 21 février 2022 14:02:11
Attachments:
image001.jpg
CBD_in_Cosmetics_-__current_Situation_in_the_EU.pdf
Importance:
High
Dear 
,
last year (January 2021) I asked 
 for support on CBD and
the legal situation in the European Union.
The situation for competent authorities in the EU, as explained in the
document attached, has unfortunately not changed for the best. There is
still a lack of legal certainty for the competent authorities or, with regard to
safety assessment, of generally accepted toxicological parameters (e.g.
NOAEL) as a starting point for a safety assessment.
The Commission's response is always the same - a solution is sought on a
horizontal level.
A similar situation currently exists on the food sector, where it has been
legally clarified that CBD has been classified as a novel food. Nevertheless,
toxicological data for assessing the safety of CBD are also lacking here. So
far, there is no authorisation.
With the urgent request to take up the issue – perhaps in the next meeting
of the Standing Committee March 2022
Best regards
Federal Ministry of Social Affairs, Health,
Care and Consumer Protection
Section III – Consumer Policy and Consumer Health
Unit III/A/6 – Food safety and Consumer protection:
Material and technological risks, Genetic engineering
Radetzkystraße 2, 1030 Vienna
sozialministerium.at